The differential impact of non-anthracycline treatment regimens on pathological complete response (pCR) rates by ER status after neoadjuvant single or dual HER2 targeted therapy (NACT): A single centre experience
- Resource Type
- Journal
- Source
CANCER RESEARCH ; FEB 2020, 80 4, 3p. Supplement: S- Subject
- Language
- English
- ISSN
- 15387445